By Deborah Cho I’m a little late to this discussion, but I want to talk briefly about the ALS Ice Bucket Challenge and how we make our decisions on charitable giving. I’m sure by now most readers understand the basic concept of the challenge: individuals can choose to either record a video of themselves pouring ice…
By Arthur Caplan Art Caplan has a new video on Medscape laying out the principles behind rationing limited supplies of experimental ebola treatments. As he explains: I believe the answer to the question of who should receive the drug is: people we can both learn from and potentially help the most. I believe those are the 2 values…
By Annette Rid In “Ethical considerations of experimental interventions in the Ebola outbreak“, published yesterday by The Lancet, Zeke Emanuel and I discuss what we take to be the key ethical questions about the use of Zmapp and other investigational agents in the current Ebola epidemic. In essence, we argue that the national and international…
By Kevin Outterson A short article in the New Yorker on my favorite topic – business models for antibiotic use and innovation.
By Arthur Caplan Art Caplan has a series of new opinion pieces out on the WHO ethics advisory committee meeting that approved the use of experimental drugs to treat patients ill with Ebola. He suggests deeper exploration of issues of informed consent, corporate responsibility, and resource allocation in this blog post for The Health Care…
By Arthur Caplan Amidst news from Spain that a 75-year-old Catholic priest has received the experimental treatment ZMapp for Ebola, Art Caplan critiques what he describes as the “bad science” behind choosing its recipients: ZMapp is not the answer to the Ebola epidemic ravaging West Africa. There is no chance of getting a significant amount of this drug…
By Ross D. Silverman Earlier this week, the World Health Organization, responding both to the international outcry over the rapidly rising number of Ebola cases and deaths across sub-Saharan Africa (and critiques of the speed of their action), and the news that western health care workers and ministry had found ways to get access to…
By Arthur Caplan As the WHO announced today that medical ethicists will convene next week in New York to discuss the use of experimental medicines in the West African Ebola outbreak, Art Caplan has a timely new opinion piece in the Washington Post asking why only white American victims of the Ebola outbreak have been treated with an experimental…
By Arthur Caplan Art Caplan has a new opinion piece on NBC News responding to the recent media coverage of Ebola. He makes the case that although this has been the worst recorded outbreak of the disease, citizens of developed countries have little reason to panic: Ebola is not going to run amok in downtown Boston, Cape May or…
